Literature DB >> 21571536

Elucidation of common pharmacophores from analysis of targeted metabolites transported by the multispecific drug transporter-Organic anion transporter1 (Oat1).

Valentina L Kouznetsova1, Igor F Tsigelny, Megha A Nagle, Sanjay K Nigam.   

Abstract

Organic anion transporter 1 (Oat1), first identified as NKT, is a multispecific transporter responsible for the handling of drugs and toxins in the kidney and choroid plexus, but its normal physiological role appears to be in small molecule metabolite regulation. Metabolites transported by Oat1 and which are altered in the blood and urine of the murine Oat1 knockout, may serve as templates for further drug design. This may lead to better tissue targeting of drugs or design of Oat1 inhibitors that prolong the half-life of current drugs. Due to the multispecificity of the transporter, 19 of known targeted metabolites have different chemical structures and properties that make constructing a common pharmacophore model difficult. Here we propose an approach that clustered the metabolites into four distinct groups which allowed for the construction of a consensus pharmacophore for each cluster. The screening of commercial molecular databases determined the top candidates whose interaction with Oat1 was confirmed in an experimental model of organic anion transport. Thus, these candidate selections represent potential molecules for further drug design.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21571536      PMCID: PMC3310230          DOI: 10.1016/j.bmc.2011.04.045

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  13 in total

1.  Flexible alignment of small molecules.

Authors:  P Labute; C Williams; M Feher; E Sourial; J M Schmidt
Journal:  J Med Chem       Date:  2001-05-10       Impact factor: 7.446

2.  Combinatorial library design from reagent pharmacophore fingerprints.

Authors:  Hongming Chen; Ola Engkvist; Niklas Blomberg
Journal:  Methods Mol Biol       Date:  2011

Review 3.  The multispecific organic anion transporter family: properties and pharmacological significance.

Authors:  Hiroki Miyazaki; Takashi Sekine; Hitoshi Endou
Journal:  Trends Pharmacol Sci       Date:  2004-12       Impact factor: 14.819

4.  Virtual screening workflow development guided by the "receiver operating characteristic" curve approach. Application to high-throughput docking on metabotropic glutamate receptor subtype 4.

Authors:  Nicolas Triballeau; Francine Acher; Isabelle Brabet; Jean-Philippe Pin; Hugues-Olivier Bertrand
Journal:  J Med Chem       Date:  2005-04-07       Impact factor: 7.446

Review 5.  Evaluation of the performance of 3D virtual screening protocols: RMSD comparisons, enrichment assessments, and decoy selection--what can we learn from earlier mistakes?

Authors:  Johannes Kirchmair; Patrick Markt; Simona Distinto; Gerhard Wolber; Thierry Langer
Journal:  J Comput Aided Mol Des       Date:  2008-01-15       Impact factor: 3.686

6.  Molecular cloning and characterization of NKT, a gene product related to the organic cation transporter family that is almost exclusively expressed in the kidney.

Authors:  C E Lopez-Nieto; G You; K T Bush; E J Barros; D R Beier; S K Nigam
Journal:  J Biol Chem       Date:  1997-03-07       Impact factor: 5.157

7.  Decreased renal organic anion secretion and plasma accumulation of endogenous organic anions in OAT1 knock-out mice.

Authors:  Satish A Eraly; Volker Vallon; Duke A Vaughn; Jon A Gangoiti; Kerstin Richter; Megha Nagle; Julio C Monte; Timo Rieg; David M Truong; Jeffrey M Long; Bruce A Barshop; Gregory Kaler; Sanjay K Nigam
Journal:  J Biol Chem       Date:  2005-12-14       Impact factor: 5.157

8.  Developmentally regulated expression of organic ion transporters NKT (OAT1), OCT1, NLT (OAT2), and Roct.

Authors:  A Pavlova; H Sakurai; B Leclercq; D R Beier; A S Yu; S K Nigam
Journal:  Am J Physiol Renal Physiol       Date:  2000-04

Review 9.  Toward a systems level understanding of organic anion and other multispecific drug transporters: a remote sensing and signaling hypothesis.

Authors:  Sun-Young Ahn; Sanjay K Nigam
Journal:  Mol Pharmacol       Date:  2009-06-10       Impact factor: 4.436

10.  Multi-level analysis of organic anion transporters 1, 3, and 6 reveals major differences in structural determinants of antiviral discrimination.

Authors:  David M Truong; Gregory Kaler; Akash Khandelwal; Peter W Swaan; Sanjay K Nigam
Journal:  J Biol Chem       Date:  2008-01-03       Impact factor: 5.157

View more
  8 in total

Review 1.  The organic anion transporter (OAT) family: a systems biology perspective.

Authors:  Sanjay K Nigam; Kevin T Bush; Gleb Martovetsky; Sun-Young Ahn; Henry C Liu; Erin Richard; Vibha Bhatnagar; Wei Wu
Journal:  Physiol Rev       Date:  2015-01       Impact factor: 37.312

2.  Molecular Properties of Drugs Interacting with SLC22 Transporters OAT1, OAT3, OCT1, and OCT2: A Machine-Learning Approach.

Authors:  Henry C Liu; Anne Goldenberg; Yuchen Chen; Christina Lun; Wei Wu; Kevin T Bush; Natasha Balac; Paul Rodriguez; Ruben Abagyan; Sanjay K Nigam
Journal:  J Pharmacol Exp Ther       Date:  2016-08-03       Impact factor: 4.030

3.  An Organic Anion Transporter 1 (OAT1)-centered Metabolic Network.

Authors:  Henry C Liu; Neema Jamshidi; Yuchen Chen; Satish A Eraly; Sai Yee Cho; Vibha Bhatnagar; Wei Wu; Kevin T Bush; Ruben Abagyan; Bernhard O Palsson; Sanjay K Nigam
Journal:  J Biol Chem       Date:  2016-07-20       Impact factor: 5.157

Review 4.  What do drug transporters really do?

Authors:  Sanjay K Nigam
Journal:  Nat Rev Drug Discov       Date:  2014-12-05       Impact factor: 84.694

5.  Unique metabolite preferences of the drug transporters OAT1 and OAT3 analyzed by machine learning.

Authors:  Anisha K Nigam; Julia G Li; Kaustubh Lall; Da Shi; Kevin T Bush; Vibha Bhatnagar; Ruben Abagyan; Sanjay K Nigam
Journal:  J Biol Chem       Date:  2020-01-02       Impact factor: 5.157

6.  Handling of Drugs, Metabolites, and Uremic Toxins by Kidney Proximal Tubule Drug Transporters.

Authors:  Sanjay K Nigam; Wei Wu; Kevin T Bush; Melanie P Hoenig; Roland C Blantz; Vibha Bhatnagar
Journal:  Clin J Am Soc Nephrol       Date:  2015-10-21       Impact factor: 8.237

7.  Multiple spatially related pharmacophores define small molecule inhibitors of OLIG2 in glioblastoma.

Authors:  Igor F Tsigelny; Rajesh Mukthavaram; Valentina L Kouznetsova; Ying Chao; Ivan Babic; Elmar Nurmemmedov; Sandra Pastorino; Pengfei Jiang; David Calligaris; Nathalie Agar; Miriam Scadeng; Sandeep C Pingle; Wolfgang Wrasidlo; Milan T Makale; Santosh Kesari
Journal:  Oncotarget       Date:  2017-04-04

8.  Molecular Properties of Drugs Handled by Kidney OATs and Liver OATPs Revealed by Chemoinformatics and Machine Learning: Implications for Kidney and Liver Disease.

Authors:  Anisha K Nigam; Anupam A Ojha; Julia G Li; Da Shi; Vibha Bhatnagar; Kabir B Nigam; Ruben Abagyan; Sanjay K Nigam
Journal:  Pharmaceutics       Date:  2021-10-18       Impact factor: 6.321

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.